Drug Use Investigation of Kovaltry in Hemophilia A Patients

CompletedOBSERVATIONAL

Enrollment

230

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 23, 2022

Study Completion Date

September 16, 2025

Conditions

Hemophilia A

Interventions

DRUG

Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973)

Treatment parameters following the physician's decision based on the summary of product characteristics.

Trial Locations (1)

Many Locations, Multiple Locations